{"id":129728,"date":"2024-04-12T16:10:50","date_gmt":"2024-04-12T14:10:50","guid":{"rendered":"https:\/\/prod1-sb.designtech.space\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/"},"modified":"2024-07-04T18:15:59","modified_gmt":"2024-07-04T16:15:59","slug":"cube-labs-ftherapeutics-agreement-for-new-drug-development","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/","title":{"rendered":"Cube Labs FTherapeutics Agreement for New Drug Development"},"content":{"rendered":"<p><strong>Cube Labs, the Italian venture builder in the life sciences sector listed on EGM Pro, and FTherapeutics, a Spanish cluster of companies<\/strong> that provides consulting services for the discovery and development of new drugs, announce a strategic collaboration agreement.<\/p>\n<p>Through the agreement, FTherapeutics, together with its cluster companies Synthelia Organics, a provider of medicinal chemistry and synthesis solutions for the pharmaceutical and biotechnology industries, and Nostrum Biodiscovery, a company specializing in AI-based biotechnology solutions for drug discovery, will collaborate with Cube Labs to advance early-stage drug discovery and development projects.<\/p>\n<p>FTherapeutics brings together professionals with long experience in multinational pharmaceutical companies such as Ely Lilly and GSK, experts in disciplines such as computational chemistry, organic chemistry, biochemistry and medicinal chemistry.<\/p>\n<p>The collaboration will leverage the complementary strengths of both parties. <a href=\"https:\/\/www.startupbusiness.it\/adams-biotech-raccoglie-470mila-euro\/123361\/\" target=\"_blank\" rel=\"noopener\">Cube Labs<\/a> will bring its expertise in identifying and building promising life science companies from the ground up. FTherapeutics and its cluster companies will contribute their expertise in drug discovery, personalized synthesis, <em>route optimization<\/em> , and artificial intelligence.<\/p>\n<p><strong>&#8220;We are thrilled to partner with FTherapeutics and the companies in the cluster,&#8221; said Filippo Surace, CEO and founder of Cube Labs<\/strong> This partnership will allow us to further enhance the value of our portfolio companies and accelerate the development of innovative new medicines.&#8221;<\/p>\n<p><strong>&#8220;This agreement represents an important step forward for FTherapeutics and for our companies in the cluster,&#8221; said Rafael Ferritto, Director of FTherapeutics.<\/strong> By partnering with Cube Labs, we will be able to bring our expertise to a wider range of early-stage drug discovery projects.&#8221; <em>(Photo by <a href=\"https:\/\/unsplash.com\/it\/@roberto_sorin?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash\">Roberto Sorin<\/a> on <a href=\"https:\/\/unsplash.com\/it\/foto\/una-pila-di-pillole-sedute-una-accanto-allaltra-in-cima-a-un-tavolo-RS0-h_pyByk?utm_content=creditCopyText&amp;utm_medium=referral&amp;utm_source=unsplash\">Unsplash<\/a>)<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Italian venture builder and Spanish business cluster sign partnership to accelerate development of life science innovations<\/p>\n","protected":false},"author":125,"featured_media":137200,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[1144,1137,1407,1136],"companies":[],"journalist":[1513],"class_list":["post-129728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-europe-en","tag-italy-en","tag-life-sciences","tag-startup-en-2","journalist-emil-abirascid-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","width":150,"height":99,"crop":false,"srcset":false,"alt":""},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","width":1024,"height":676,"crop":false,"srcset":false,"alt":""},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","width":1280,"height":845,"crop":false,"srcset":false,"alt":""}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cube Labs FTherapeutics Agreement for New Drug Development<\/title>\n<meta name=\"description\" content=\"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cube Labs FTherapeutics Agreement for New Drug Development\" \/>\n<meta property=\"og:description\" content=\"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-12T14:10:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-04T16:15:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"845\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"Cube Labs FTherapeutics Agreement for New Drug Development\",\"datePublished\":\"2024-04-12T14:10:50+00:00\",\"dateModified\":\"2024-07-04T16:15:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/\"},\"wordCount\":269,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/roberto-sorin-RS0-h_pyByk-unsplash.jpg\",\"keywords\":[\"Europe\",\"italy\",\"Life Sciences\",\"startup\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/\",\"name\":\"Cube Labs FTherapeutics Agreement for New Drug Development\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/roberto-sorin-RS0-h_pyByk-unsplash.jpg\",\"datePublished\":\"2024-04-12T14:10:50+00:00\",\"dateModified\":\"2024-07-04T16:15:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/cube-labs-ftherapeutics-agreement-for-new-drug-development\\\/129728\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/roberto-sorin-RS0-h_pyByk-unsplash.jpg\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/roberto-sorin-RS0-h_pyByk-unsplash.jpg\",\"width\":1280,\"height\":845},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cube Labs FTherapeutics Agreement for New Drug Development","description":"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/","og_locale":"en_US","og_type":"article","og_title":"Cube Labs FTherapeutics Agreement for New Drug Development","og_description":"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations","og_url":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/","og_site_name":"Startupbusiness.it","article_published_time":"2024-04-12T14:10:50+00:00","article_modified_time":"2024-07-04T16:15:59+00:00","og_image":[{"width":1280,"height":845,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","type":"image\/jpeg"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"Cube Labs FTherapeutics Agreement for New Drug Development","datePublished":"2024-04-12T14:10:50+00:00","dateModified":"2024-07-04T16:15:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/"},"wordCount":269,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","keywords":["Europe","italy","Life Sciences","startup"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/","url":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/","name":"Cube Labs FTherapeutics Agreement for New Drug Development","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","datePublished":"2024-04-12T14:10:50+00:00","dateModified":"2024-07-04T16:15:59+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"Italian venture builder and Spanish business cluster sign partnership for the development of life science innovations","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/cube-labs-ftherapeutics-agreement-for-new-drug-development\/129728\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2024\/06\/roberto-sorin-RS0-h_pyByk-unsplash.jpg","width":1280,"height":845},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/84e46190ac811c9c62650621ceca8f65c1e967d6b06e6352fe183145dba0d7e9?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":[],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=129728"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129728\/revisions"}],"predecessor-version":[{"id":141198,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/129728\/revisions\/141198"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/137200"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=129728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=129728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=129728"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=129728"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=129728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}